| 0 (0%) | 12-27 00:26 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 18.38 | 1-year : | 21.47 |
| Resists | First : | 15.73 | Second : | 18.38 |
| Pivot price | 11.62 |
|||
| Supports | First : | 11.7 | Second : | 9.21 |
| MAs | MA(5) : | 12.23 |
MA(20) : | 11.95  |
| MA(100) : | 8.27 |
MA(250) : | 0 | |
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 82.8 |
D(3) : | 64.8 |
| RSI | RSI(14): 59.6 |
|||
| 52-week | High : | 15.73 | Low : | 2.68 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NXTC ] has closed below upper band by 8.8%. Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 12.94 - 13 | 13 - 13.04 |
| Low: | 12.13 - 12.22 | 12.22 - 12.27 |
| Close: | 12.64 - 12.78 | 12.78 - 12.86 |
Fri, 26 Dec 2025
NXTC Stock Analysis and Forecast - Earnings Call Summaries & Target Triple-Digit Stock Opportunities - earlytimes.in
Fri, 19 Dec 2025
NextCure Launches At-The-Market Stock Offering Program - TipRanks
Thu, 20 Nov 2025
NextCure (Nasdaq: NXTC) in fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan
Mon, 17 Nov 2025
NextCure, Inc. Secures $21.5 Million in Private Placement, Extending Cash Runway into First Half of 2027 - Quiver Quantitative
Wed, 12 Nov 2025
NextCure (NASDAQ: NXTC) announces $21.5M private placement to extend runway into 2027 - Stock Titan
Wed, 12 Nov 2025
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 3 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 20.1 (%) |
| Held by Institutions | 32.8 (%) |
| Shares Short | 21 (K) |
| Shares Short P.Month | 30 (K) |
| EPS | -23.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.84 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -58.1 % |
| Return on Equity (ttm) | -117 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -17.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -49 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -0.54 |
| PEG Ratio | 0 |
| Price to Book value | 1.44 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|